SCHEMBL11022049

SCHEMBL11022049

CCc1cccc(Cl)c1-c1ccccc1OCCCCCCCCl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 8/20 0.41
MAPT P10636 4/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KCNA3 P22001 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
HPGD P15428 2/20 0.40
ATM Q13315 1/20 0.40
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
KCNH2 Q12809 1/20 0.39
KDM4E B2RXH2 2/20 0.36
LTB4R Q15722 1/20 0.36
LTB4R2 Q9NPC1 1/20 0.36
LMNA P02545 2/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11018477 0.92 L3MBTL1 (0.47) L3MBTL1MAPTNPSR1KCNA3TDP1
SCHEMBL11020806 0.90 KCNA3 (0.39) L3MBTL1MAPTNPSR1KCNA3TDP1
SCHEMBL11022872 0.87 KDM4E (0.52) TDP1KDM4ELMNASMN1; SMN2
SCHEMBL11024159 0.85 MAOB (0.48) L3MBTL1MAPTHPGDNPC1RAB9A
SCHEMBL11022638 0.85 L3MBTL1 (0.44) L3MBTL1MAPTNPSR1KCNA3HPGD
SCHEMBL11023064 0.81 L3MBTL1 (0.45) L3MBTL1MAPTNPSR1KCNA3HPGD
SCHEMBL11020827 0.79 L3MBTL1 (0.46) L3MBTL1MAPTNPSR1KCNA3HPGD
SCHEMBL10678890 0.78 L3MBTL1 (0.43) L3MBTL1MAPTNPSR1KCNA3HPGD
SCHEMBL11021329 0.78 L3MBTL1 (0.43) L3MBTL1MAPTNPSR1KCNA3TDP1
SCHEMBL10683857 0.77 L3MBTL1 (0.41) L3MBTL1MAPTTDP1HPGDATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0157652-A1 2-, 3- And 4-biphenyloxyaminoalkanes and related compounds, their preparation and uses, and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-10-09 EP disclosed